Travatan Z
These highlights do not include all the information needed to use TRAVATAN Z safely and effectively. See full prescribing information for TRAVATAN Z. TRAVATAN Z (travoprost ophthalmic solution), for topical ophthalmic useInitial U.S. Approval: 2001
Approved
Approval ID
028455e0-ae77-4213-8819-3b58ef7d6a14
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 27, 2023
Manufacturers
FDA
Novartis Pharmaceuticals Corporation
DUNS: 002147023
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
travoprost
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0078-0946
Application NumberNDA021994
Product Classification
M
Marketing Category
C73594
G
Generic Name
travoprost
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJuly 12, 2022
FDA Product Classification
INGREDIENTS (9)
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
TRAVOPROSTActive
Quantity: 0.04 mg in 1 mL
Code: WJ68R08KX9
Classification: ACTIB
POLYOXYL 40 CASTOR OILInactive
Code: 4ERD2076EF
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
ZINC CHLORIDEInactive
Code: 86Q357L16B
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT